Zoe Arvanitakis, MD, MS, is the Acting Chairperson of the Department of Neurological Sciences, at the Rush Medical College of Rush University. She is the Medical Director of the Rush Memory Clinic, at the Rush Alzheimer’s Disease Center. A Professor of Neurological Sciences, she is a board-certified neurologist (certified by the American Board of Psychiatry and Neurology, with re-certification) and subspecialist in cognitive neurology and dementia, with fellowship training from the Mayo Clinic. She has more than two decades of clinical experience in cognitive clinical care, research, and education. The Rush Memory Clinic, under the leadership of Arvanitakis, provides expert subspecialty clinical care to improve the overall health and well-being of older adults with memory and cognitive-behavioral changes through expert diagnosis, care planning, and opportunities for research participation. Arvanitakis is recognized as an effective and energetic educator who teaches at the medical school and within Rush, as well as at national conferences and meetings, and has received an award from Rush for her excellence in mentoring.
Arvanitakis is also an academic clinical neuroscientist with expertise in biomedical research, with a Master of Science (MS) in Clinical Research, and subspecialization in epidemiology. Arvanitakis is Principal Investigator of research grants from the National Institutes of Health (NIH), including investigator-initiated grants (R01s), and is Principal Investigator of clinical trials and co-investigator on several other NIH-funded and additional projects. Arvanitakis has published original research in peer-reviewed medical journals in the field of neurodegenerative, vascular, and metabolic cognitive impairment and dementia, including publications on the topics of Alzheimer’s disease and mechanisms of dementia. In addition to her many publications, Arvanitakis has also co-edited a medical textbook. Her collaborative research leverages clinical, laboratory, neuroimaging and other data, and human biospecimens, from several large, epidemiologic, longitudinal, clinical-pathologic cohort studies of aging at the Rush Alzheimer’s Disease Center. She serves on numerous national and international funding agency, scientific journal, and meeting abstract review panels. She is a member of the NIH Neurological, Aging and Musculoskeletal Epidemiology (NAME) study section. Arvanitakis is internationally recognized scientific speaker in the field of neurologic aging and dementia. She is a past chair of the Geriatric Neurology Section of the American Academy of Neurology (AAN), the largest professional organization of neurologists in the world. Arvanitakis is an elected Fellow of the American Academy of Neurology (FAAN) and an elected Fellow of the American Neurological Association (FANA).
